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Abstract: Immune system functionality has been commonly assessed by a whole-blood or isolated-
cell stimulation assay. The aim of this study was to determine whether cytokine production in
whole-blood-stimulated samples is influenced by age, sex, and smoking. A descriptive cross-sectional
study in 253 healthy participants aged 18–55 years was conducted. Whole blood samples were
stimulated for 24 h with LPS and concentrations of IL-6, IL-10, and TNF-α were determined in
the culture media. Among parameters considered, statistical regression analysis indicated that
smoking (change in R2 = 0.064, p < 0.001) and sex (change in R2 = 0.070, p < 0.001) were the main
predictors for IL-10 production, with higher values for women and non-smokers. Age was also
found to be a significant predictor (change in R2 = 0.021, p < 0.001), with higher values for younger
ages. Age (change in R2 = 0.089, p = 0.013) and smoking (change in R2 = 0.037, p = 0.002) were
found to be negative predictors for IL-6 production. Regarding TNF-α-stimulated production, age
(change in R2 = 0.029, p = 0.009) and smoking (change in R2 = 0.022, p = 0.022) were found to be
negative predictors. Furthermore, sex (change in R2 = 0.016, p = 0.045) was found to be a significant
predictor, with lower values for women. In conclusion, sex, age, and smoking were found to be
independent determinants of stimulated cytokine production. While female sex is associated with
higher IL-10 and lower TNF-α production, aging and smoking are associated with lower IL-6, IL-10,
and TNF-α production.
Keywords: LPS challenge; blood culture; age; sex; smoking; menstrual cycle
1. Introduction
The capacity of leukocytes to produce cytokines upon adequate challenge has been
considered an interesting question with potential consequences for the entire functional
capacity of the immune system [1]. In this regard, immune responsiveness has been
commonly assessed by a whole-blood or isolated-cell stimulation assay, which measures the
culture concentration of cytokines produced by immune cells upon stimulation with, among
others, the Gram-negative stimulus lipopolysaccharide (LPS). [2]. This stimulation assay
primarily assesses individuals’ cytokine production by monocytes [3], a process reported
to be under genetic control [4]. Monocyte-derived cytokines are involved in immune
responses such as the activation of B cells, leading to the production of specific antibodies,
the activation of T cells, leading to cell-mediated immunity, and the enhancement of several
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neutrophil and macrophage/monocyte functions [5]. Consequently, monocyte-derived
cytokines play important roles in host defense against bacterial infections [5].
Measurement of LPS-stimulated cytokine production has been used as a model of im-
mune responsiveness in non-infectious diseases [2]. A low stimulated cytokine production
has been associated with increased mortality [6], metabolic syndrome and type 2 dia-
betes [7], lower serum triiodothyronine levels [8], and lower muscle mass and strength [9],
all of which are considered as consequences of the aging process. Furthermore, it has been
reported that monocytes from depressed patients present an altered response to endotoxin
stimulation [10]. However, whether the cytokine production response plays a causal role in
the development of these diseases still needs to be determined [2].
The effect of sex on LPS-stimulated cytokine production remains unclear. While
some studies have reported a higher stimulated cytokine production in men than in
women [2,11–13], others have found no sex differences [14]. In this regard, age has been
suggested to be an important factor, as sex differences seem to be higher in young people [2].
Regarding age, the influence of aging on the production of cytokines by monocytes has
also been investigated, and an impaired ability to produce interleukin (IL)-1β and tumor
necrosis factor (TNF)-α with aging has been shown [5,11,15]. However, most of these
studies have compared the stimulated cytokine production in elderly (older than 70 years)
and in young (around 25–30 years old) populations [5,11]. Whether decreases with aging
become significant in the elderly or in earlier ages has not been tested.
The aim of this study was to determine whether the cytokine production in whole-
blood-stimulated samples from a young and healthy population is influenced by age, sex,
and smoking. In women, the influence of the menstrual cycle was also analyzed.
2. Materials and Methods
2.1. Study Design and Participants
A descriptive, cross-sectional study was conducted. All participants were informed of
the purpose and demands of the study before giving their written consent to participate.
The protocol was in accordance with the Declaration of Helsinki for research involving
human subjects and was approved by the Balearic Islands Clinical Investigation Ethics Com-
mittee (IB 2399/14 PI). All participants were residents in Mallorca (Balearic Islands, Spain).
Participants were enrolled after fulfilling all inclusion criteria and presenting none of the
exclusion criteria. Participants could be included if they were currently healthy and aged
18–55 years old. Exclusion criteria were common cold, flu or similar diseases, infectious
disease or allergic episodes within the previous two weeks, regular alcohol (more than one
daily drink in women and two daily drinks in men) or drugs consumption, consumption
within the 2 weeks preceding the study of anti-inflammatory medication, and pregnancy.
Initially, 255 participants were recruited, but blood could not be obtained from two, and
the blood volume taken from three was not enough to perform the stimulation experiences,
leading to the final number of 253 participants. Most participants were recruited among
students and staff from the University of the Balearic Islands. This allows to ensure that
these participants were under similar work-related LPS exposure, one of the factors that
could influence cytokine production.
2.2. Laboratory Visit
Participants arrived at the laboratory between 08:00 a.m. and 10:00 a.m. following an
overnight fast of approximately 12 h. They had been previously informed about the study
demands and about the inclusion and exclusion criteria. They had also been instructed
to abstain from any moderate-vigorous intensity exercise during the 24 h before arriving
at the laboratory. Smokers were asked to refrain from smoking before the visit (since
they woke up). Information about the study was reiterated again to the participants, they
completed an inclusion/exclusion criteria questionnaire, and they then signed an informed
consent form. Each participant was asked to empty their bladder before body mass, height,
and body composition were recorded. Stature was measured to the nearest 0.5 cm using
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a stadiometer (Seca 220 (CM) Telescopic Height Rod for Column Scales, Seca GmbH,
Hamburg, Germany). Body mass was measured to the nearest 0.1 kg using an electronic
scale (Seca 700, Seca GmbH, Hamburg, Germany). Body mass index (BMI) was calculated as
weight (kg) divided by height (m) squared (kg·m−2). Smoking habit was ascertained, and
participants were classified as smokers or non-smokers. Smokers were asked about the daily
number of cigarettes consumed. Female participants were asked about the date of their last
menstrual bleed. The period week was ascertained considering this date and a four-week
period duration. Participants then sat quietly for 10 min before a blood sample was taken.
Seated venous blood samples were collected in suitable Vacutainer®blood collection tubes
with ethylenediaminetetraacetic acid (EDTA) or heparin as an anticoagulant (BD, Madrid,
Spain). Blood cell numbers (leukocytes, neutrophils, lymphocytes, and monocytes) were
quantified in the EDTA blood sample using an automatic flow cytometer analyzer (ABX
Pentra 60, Horiba Medical, Montpellier, France). Blood collected with heparin was used for
the blood culture experiences.
2.3. Blood Culture and LPS Stimulation
Diluted whole heparin blood (1:3 with culture media, RPMI-1640 Medium, Sigma,
St Louis, MO, USA) was incubated into sterile 12-well plates (Sarstedt, Nümbrecht, Ger-
many) with lipopolysaccharide (Escherichia coli serotype 055:B5; Sigma, St Louis, MO, USA;
final concentration 10 ng/mL), or with the same volume of culture media (spontaneous
production) for 24 h at 37 ◦C. Immediately after incubation, samples were centrifuged at
1000× g for 10 min to obtain the supernatants. Aliquots of these culture supernatants were
stored at −70 ◦C until assayed.
2.4. Cytokine Measurements
Concentrations of IL-10, IL-6, and TNF-α were determined in the culture super-
natants using commercially available enzyme-linked immunosorbent assay kits (Invit-
rogen, Carlsbad, CA, USA), with a spectrophotometric microplate reader (PowerWavei;
BioTek, Winooski, VT, USA). Monocyte numbers were used to normalize cytokine produc-
tion on a per-cell basis [1,16]. Cytokine-stimulated production is reported as the difference
between cytokine concentration in stimulated and unstimulated cultures.
2.5. Statistical Analysis
Statistical analysis was carried out using IBM SPSS Statistics 22.0 software (IBM,
Chicago, IL, USA). All data were tested for normal distribution (Kolmogorov–Smirnov
test), and it was found that cytokine-stimulated production values did not follow a normal
distribution. The results were expressed as means and standard deviations (SD), or median
and interquartile ranges, as specified. Percentages were also used when required. General
characteristics of participants were compared using a t-test for unpaired data. The Mann–
Whitney U test was used to evaluate differences between sexes and between smoker
and non-smoker participants in cytokine-stimulated production. Kruskal–Wallis one-
way ANOVA was used to determine the effect of the menstrual cycle week on cytokine
production in women, as well as the significance of the changes in cytokine production
in participants stratified per age. For this last analysis, five age groups were considered:
18–19, 20–29, 30–39, 40–49, and 50–55 years old. The existence of significant bivariate
correlations between cytokine production (logarithmic transformed), age, and BMI was
ascertained by determining Pearson correlation coefficients. Multiple linear regression
analysis, using the stepwise procedure, was applied to determine the association between
each dependent variable (log10 transformed IL-10, IL-6 and TNF-α-stimulated production)
and independent (age, sex, and smoking status) and control variables (BMI). Statistical
significance was accepted at p < 0.05.
Cells 2022, 11, 103 4 of 12
3. Results
3.1. General Characteristics of Participants in the Study
Table 1 shows the general characteristics of participants in the study. Higher values
for body mass (p < 0.001), stature (p < 0.001) and BMI (p < 0.001) in men than in women
were observed. No differences between men and women were found for age (p = 0.534),
leukocyte (p = 0.681), neutrophil (p = 0.363), lymphocyte (p = 0.674) and monocyte (p = 0.407)
counts. Among participants in the study, 32 were smokers (11 men and 21 women), with
an average daily consumption of 6.6 ± 10.9 cigarettes.
Table 1. General characteristics of participants in the study.




(n = 133) p Value
Age (years) 33.0 ± 10.9 33.4 ± 11.0 32.6 ± 10.9 0.534
Body mass (kg) 67.0 ± 13.5 76.3 ± 11.8 58.6 ± 8.6 <0.001 *
Stature (cm) 170.0 ± 9.6 177.0 ± 7.1 163.6 ± 6.4 <0.001 *
BMI (kg·m−2) 23.1 ± 3.4 24.3 ± 3.3 22.0 ± 3.2 <0.001 *
Leukocytes (103·µL−1) 5.84 ± 1.38 5.80 ± 1.18 5.87 ± 1.55 0.681
Neutrophils (103·µL−1) 3.13 ± 0.98 3.07 ± 0.84 3.18 ± 1.08 0.363
Lymphocytes (103·µL−1) 1.98 ± 0.60 1.96 ± 0.59 1.99 ± 0.60 0.674
Monocytes (103·µL−1) 0.49 ± 0.41 0.52 ± 0.37 0.47 ± 0.44 0.407
Values are expressed as means ± S.D. * indicates significant differences between men and women (p < 0.05).
3.2. Culture Cytokine Production
No differences per sex, age, or smoking habit were observed for unstimulated IL-
10, IL-6, and TNF-α production (results not shown). Table 2 shows cytokine production
in participants stratified by sex. Higher IL-10 (p < 0.001) but lower TNF-α (p = 0.039)
production were observed in women. No differences between sexes were observed for IL-6
production (p = 0.068).
Table 2. Cytokine-stimulated production in participants stratified by sex.
Cytokine Men(n = 120)
Women
(n = 133) p Value
IL-10 (pg·10−3 cells) 20.6 (13.5, 28.4) 29.1 (17.4, 42.1) <0.001 *
IL-6 (pg·10−3 cells) 372.8 (262.7, 536.6) 428.8 (331.7, 586.4) 0.068
TNF-α (pg·10−3 cells) 56.0 (33.9, 85.3) 49.4 (30.8, 69.1) 0.039 *
Values are expressed as median (25th, 75th percentile) and represent the difference between cytokine concentration
in stimulated and unstimulated cultures. * indicates significant differences between sexes (p < 0.05).
Table 3 shows values for cytokine production in non-smoker and smoker participants.
Significant lower productions of IL-10 (p < 0.001), IL-6 (p = 0.003) and TNF-α (p = 0.033)
were observed in smokers.
The analysis of cytokine production stratified by age groups revealed a significant
influence of age on IL-6 (p = 0.001) and TNF-α (p = 0.003) stimulated production. However,
although a decreasing trend in IL-10 production with age was observed, the effect was
not significant (p = 0.240, Figure 1a). IL-6 production in the group aged 20–29 years was
significantly higher than in groups aged 40–49 (p = 0.039) and 50–55 (p = 0.002) years
(Figure 1b). IL-6 production in the group aged 30–39 years was also significantly higher
than in the group aged 50–55 years old (p = 0.015). TNF-α production in participants
aged 20–29 and 30–39 years was higher than in the group aged 50–55 years (p = 0.039 and
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p = 0.024, respectively, Figure 1c). Furthermore, TNF-α production was lower in the group
aged 18–19 years than in groups aged 20–29 (p = 0.039) and 30–39 (p = 0.042) years.
Table 3. Cytokine-stimulated production in smoker and non-smoker participants.
Cytokine Non-smokers(n = 221)
Smokers
(n = 32) p Value
IL-10 (pg·10−3 cells) 25.0 (16.3, 35.7) 14.3 (10.5, 22.6) <0.001 *
IL-6 (pg·10−3 cells) 397.8 (299.0, 562.0) 288.3 (223.2, 445.4) 0.003 *
TNF-α (pg·10−3 cells) 53.0 (34.1, 81.5) 42.1 (26.8, 60.0) 0.033 *
Values are expressed as median (25th; 75th percentile) and represent the difference between cytokine con-
centration in stimulated and unstimulated cultures. * indicates significant differences between smokers and
non-smokers (p < 0.05).
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When correlations between cytokine production (logarithmic transformations) and 
continuous dependent variables (age and BMI) were analyzed, it was observed that IL-10 
(r = −0.267, p = 0.021) and IL-6 (r = −0.267, p < 0.001) production were significantly correlated 
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3.4. Linear Regression Analysis for IL-6-, IL-10-, and TNF-α-Stimulated Production 
Table 4 shows the results of the regression analysis for IL-10 production (significant 
predictors). Model 1 includes smoking as the significant predictor (change in R2 = 0.064, p 
< 0.001), with higher IL-10-stimulated production for non-smokers. Model 2 incorporates 
Figure 1. IL-10 (a), IL-6 (b), and TNF-α (c) stimulated production stratified by age groups. Median,
25th, 75th percentile, and lowest and highest values for cytokine production are shown. Age 18–19, n
= 22; age 20–29, n = 82; age 30–39, n = 63; age 40–49, n = 51; age 50–55, n = 35. “a” indicates significant
differences vs. 20–29 y group, “b” indicates significant differences vs. 30–39 y group (p < 0.05).
3.3. Correlations between Cytokine-Stimulated Production, Age, and BMI
When correlations between cytokine production (logarithmic transformations) and contin-
uous dependent variables (age and BMI) were analyzed, it was observed that IL-10 (r = −0.267,
p = 0.021) and IL-6 (r = −0.267, p < 0.001) production were significantly correlated with age.
Furthermore, IL-10 production was correlated with BMI (r = −0.159, p = 0.012).
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3.4. Linear Regression Analysis for IL-6-, IL-10-, and TNF-α-Stimulated Production
Table 4 shows the results of the regression analysis for IL-10 production (significant
predictors). Model 1 includes smoking as the significant predictor (change in R2 = 0.064,
p < 0.001), with higher IL-10-stimulated production for non-smokers. Model 2 incorporates
sex as a significant predictor (change in R2 = 0.070, p < 0.001), increasing R2 adjusted
value from 0.064 to 0.134, and with higher IL-10 production for women. Finally, model 3
includes age as a significant negative predictor (change in R2 = 0.021, p = 0.013), leading to
a final R2 adjusted value of 0.145, and with IL-10-simulated production decreasing with
age (β = −0.145).
Table 4. Regression models for IL-10-stimulated production.




Model 1 0.064 0.060 <0.001 * 0.064
Smoking −0.196 −0.253 (−0.289, −0.103) −4.148 <0.001 *
Model 2 0.134 0.127 <0.001 * 0.070
Smoking −0.216 −0.280 (−0.306, −0.126) −4.731 <0.001 *
Sex 0.137 0.266 (0.077, 0.197) 4.504 <0.001 *
Model 3 0.155 0.145 <0.001 * 0.021
Smoking −0.220 −0.285 (−0.309, −0.131) −4.859 <0.001 *
Sex 0.134 0.261 (0.075, 0.194) 4.459 <0.001 *
Age −0.003 −0.145 (−0.006, −0.001) −2.490 0.013 *
Logarithmic transformation of IL-10-stimulated production was used. n = 253. B: regression coefficient; β: standardized
beta coefficient; * indicates statistically significant predictors and models (p < 0.05). The negative coefficient for smoking
indicates lower values for IL-10-stimulated production in smokers than in non-smokers. The positive coefficient for sex
indicates higher values in women than in men.
Table 5 shows the linear multiple regression models for IL-6- and TNF-α-stimulated
production (significant predictors). As it is shown in the previous section, age was not
linearly associated with IL-6 and TNF-α production, which supposes one of the assump-
tions for a variable to be included in the linear regression analysis, mainly due to values
observed for participants aged 18 and 19 years old. Therefore, only participants aged 20
and older were included in this linear regression analysis. Among factors considered, age
was found to be the main significant predictor (change in R2 = 0.089, p < 0.001) for IL-6
production (model 1). Within participants considered in this analysis, IL-6-stimulated
production decreased with age (β = −0.298). In addition, model 2 includes smoking as a
significant predictor (change in R2 = 0.037, p = 0.002), increasing adjusted R2 from 0.085 to
0.118, and with higher productions for non-smokers. In a similar way, model 1 for TNF-α
production included age as the significant, and negative, predictor (β = −0.170, change in
R2 = 0.029, p = 0.009). Model 2 for TNF-α production also includes smoking as a significant
predictor (change in R2 = 0.022, p = 0.022), increasing adjusted R2 from 0.025 to 0.042. Model
3 for TNF-α-stimulated production considers sex as the last significant predictor (change
in R2 = 0.016, p = 0.045), leading to a final adjusted R2 value of 0.067.
3.5. Effects of the Menstrual Cycle on the Cytokine-Stimulated Production
Table 6 shows the cytokine production in women stratified per menstrual cycle week.
A significant effect of the menstrual cycle on IL-10-stimulated production was observed
(p = 0.035), with higher production in the second than in the third week (p = 0.039). No
effects were observed for IL-6 (p = 0.681) and TNF-α (p = 0.383) production.
Cells 2022, 11, 103 7 of 12
Table 5. Regression models for IL-6- and TNF-α-stimulated production.





Model 1 0.089 0.085 <0.001 * 0.089
Age −0.006 −0.298 (−0.009, −0.004) −4.744 <0.001 *
Model 2 0.126 0.118 <0.001 * 0.037
Age −0.006 −0.311 (−0.009, −0.004) −5.032 <0.001 *
Smoking −0.123 −0.193 (−0.201, −0.045) −3.119 0.002 *
TNF-α
Model 1 0.029 0.025 0.009 * 0.029
Age −0.005 −0.170 (−0.009, −0.001) −2.623 0.009 *
Model 2 0.051 0.042 0.002 * 0.022
Age −0.005 −0.180 (−0.009, −0.002) −2.796 0.006 *
Smoking −0.137 −0.148 (−0.254, −0.020) −2.309 0.022 *
Model 3 0.067 0.055 0.001 * 0.016
Age −0.005 −0.181 (−0.009, −0.002) −2.836 0.005 *
Smoking −0.137 −0.132 (−0.239, −0.005) −2.309 0.041 *
Sex −0.081 −0.129 (−0.160, −0.002) −3.063 0.045 *
Logarithmic transformation of IL-6- and TNF-α-stimulated production was used. n = 231. B: regression coefficient;
β: standardized beta coefficient; * indicates statistically significant predictors and models (p < 0.05). The negative
coefficient for smoking indicates lower stimulated production in smokers than in non-smokers. The negative
coefficient for sex indicates lower values in women than in men.
Table 6. Cytokine-stimulated production Cytokine production in women stratified per menstrual
cycle week.





































Values are expressed as median (25th; 75th percentile). n = 133. p-adjusted values are reported. * indicates
statistically significant differences where “a” indicates significant differences between the third and the second
week (p < 0.05).
4. Discussion
The main findings of the present study were that women showed lower production of
the pro-inflammatory cytokine TNF-α and higher production of the anti-inflammatory cy-
tokine IL-10 than men. Furthermore, a general decrease in cytokine-stimulated production
with aging, as well as lower values in smokers than in non-smokers, were observed.
Sex, age, and smoking have been found as mutually independent determinants of
stimulated cytokine production, with a consistent contribution as the regression coefficients
of the regression analysis hardly change when another determinant was added to the
model (Tables 4 and 5). Factors considered in the present study (sex, age, and smoking)
could explain only a limited fraction of all interindividual variation in cytokine responses.
Therefore, additional factors must be considered in future studies to improve the analysis of
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the cytokine response upon stimulation. However, it should be considered that stimulated
cytokine production is under tight genetic control, which could account for over 50% of
this variability [4].
Regarding age, a decrease in the production of the cytokines with aging could be
considered as the main general observation. In accordance with the decreased stimulated
production observed in the present study, others have reported decreased LPS-induced
production of TNF-α by isolated monocytes from elderly (79 years old) compared with
young (33 years old) humans [5] and also reduced production by stimulated whole blood
in participants aged 81 years with respect to participants aged 19–30 years [11]. It is note-
worthy that in the present study, decreased production of the pro-inflammatory cytokine
TNF-α [5,11], but also of IL-6 [5], was observed for participants aged around 50 years
old, while most of the previous studies reported such decreased levels for older ages.
Although a previous study [11] did not find a decrease in IL-6-stimulated production, it
was pointed out that IL-6 production showed a strong linear correlation with the decreased
TNF-α production. The significance of this decreased production is not clear. As it has
been previously suggested, the lower production of these cytokines in the elderly may
provide an explanation for them becoming more susceptible to infections and having a poor
clinical outcome [5]. Furthermore, this decreased production may be of special importance
in elderly humans with underlying health disorders, whereas the clinical relevance is
questionable in healthy elderly [11]. It has been suggested that ex vivo LPS-stimulated
leukocytes TNF-α release could be considered a biomarker of monocytic immune capacity
and reflective of global immune competence, the persistent reduction being predictive of
adverse outcomes, and its restoration as an indicator of clinical improvement [16–19].
Regarding changes in stimulated cytokine production with aging, it is noteworthy that
TNF-α production was lower in participants aged 18–19 years old than in the ones aged
20–29 years old, a pattern also observed for IL-6 but with non-significant differences. In this
regard, as it has been indicated in the Section 3, participants aged 18–19 years were excluded
from the regression analysis because when these participants were considered age was not
simply linearly associated with cytokine (IL-6 and TNF-α)-stimulated production. However,
it should be noted that even after including all participants in the regression analysis, age
remained a significant predictor for both IL-6 and TNF-α production (results not shown).
However, the models explained a lower percentage of interindividual variation (R2 values:
IL-6: 0.105 vs. 0.126; TNF-α: 0.032 vs. 0.067). These lower values could be due, at least in
part, to the lack of a complete linear fitting between age and stimulated cytokine production
described above. Therefore, while we can conclude that aging induced lower cytokine-
stimulated production, and it seems that for the pro-inflammatory cytokines the pattern
of change in the younger participants is different. The lower pro-inflammatory cytokine
production in the youngest participants could be related to incomplete development of the
immune system, as it has been suggested that this is completed during the second decade of
life [20,21]. In fact, results from the present study suggest that the highest pro-inflammatory
cytokine production was reached at 20–29 years old. However, more studies should be
performed to further clarify this question.
Sex differences in cytokine-stimulated production were previously reviewed in a
study with results from 15 populations [2]. This study concluded that sex differences in
cytokine-stimulated production disappear when results were normalized using the mono-
cyte number, except for higher production of IL-10 in women than in men. In agreement
with this last observation, a higher stimulated IL-10 production was found in women than
in men in the present study (Table 2). Actually, sex was found as a significant predictor
for IL-10-stimulated production (Table 4). The significance of this difference is unknown.
It has been suggested that an association with reproductive success could exist, as it has
been described that reproductive success could be dependent on a strong IL-10 production
response at the fetal–maternal interface [22]. However, a previous study in physically
active participants reported that a high IL-10-stimulated production was a risk factor for
the development of upper respiratory tract infection (URTI) [23]. This effect was attributed
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to an inhibitory role of IL-10 on Th1 antiviral actions rather than to the inhibition of pro-
inflammatory cytokine production [23]. Along the same lines, it has been reported that
high IL-10 responders had wheezing symptoms more often than low IL-10 responders [24].
Furthermore, a higher pro-inflammatory cytokine and a lower anti-inflammatory pro-
duction response upon stimulation with LPS have been associated with survival from
meningococcal infection [25], a lower incidence of systemic lupus erythematosus [26], and
less severe progression of multiple sclerosis [27]. Within the healthy participants in the
present study, in addition to higher IL-10 production, lower TNF-α production in women
was observed, which is in agreement with previous observations [24,28]. This decreased
value in women has, in general, been attributed to the influence of sex hormones, mainly
estrogens [28]. The lower TNF-α production in women than in men could be one of the
factors causing the lower incidence of sepsis among women [29].
Chronic smoking has been shown to induce an important impairment in the host
defense, with nicotine playing an important role [30]. However, it is striking that a potential
therapeutic anti-inflammatory role has been attributed to nicotine, preventing some inflam-
matory and neurodegenerative diseases [30]. Regarding cytokine-stimulated production,
it has been reported that the suppressive effect of smoking is restricted to the lungs [31].
In the present study, decreased stimulated productions of the three cytokines tested were
found. The decreased IL-10 production could be attributed to nicotine because, in different
cellular models, a suppressive effect of nicotine exposure on the IL-10-stimulated produc-
tion has been found [32,33]. It is noteworthy that, in the present study, lower monocyte
numbers were found in smokers (results not shown), which could have influenced the
results observed. The decrease in IL-6 and TNF-α production could be in agreement with
previous results reporting decreased pro-inflammatory production in stimulated alveolar
macrophages [31]. However, complete molecular mechanisms leading to this impaired
immune function in smokers remain to be fully elucidated.
Previous studies have reported that monocytes produce lower levels of pro-inflammatory
cytokines both after LPS stimulation [34] and spontaneously [35] in the presence of high
concentrations of female hormones. In the present study, within female participants,
differences were found in the stimulated production of IL-10 during the menstrual cycle,
with higher production in the second than in the third week (Table 6). These results could
be explained by changes in the concentration of estrogen during the menstrual cycle. In
this regard, while the third week is characterized by low concentrations of estrogen, with
a pro-inflammatory effect, the second week is characterized by higher levels of estrogen,
with potent anti-inflammatory effects [36,37]. In fact, despite being non-significant, slightly
increased production of IL-6 and TNF-α were observed in the present study during the
third week, which could be a consequence of the pro-inflammatory characteristics of
this week. However, it is noteworthy that a previous study, using a different approach,
through which 12 cycles in only 5 women were analyzed, did not find any change in the
cytokine-stimulated production during the menstrual cycle [38].
This study presents some limitations that should be acknowledged. The production of
only two pro-inflammatory and one anti-inflammatory cytokine was measured. This, to-
gether with the observational nature of the study, could hamper, at least in part, a conclusive
and comprehensive interpretation of the effects of different factors analyzed. Furthermore,
participants in the study were recruited only in Mallorca, and therefore, the results of the
study could not be generalized elsewhere. The low number of smokers considered, together
with the lack of additional measurements related to mechanisms involved, such as nicotine
or cotinine levels, did not allow proper conclusions to be drawn regarding the effect of
smoking. Stimulation for 24 h was chosen to optimize the production of IL-10, as it has been
reported that stimulated IL-10 production is secondary to the release of proinflammatory
cytokines [39]. However, this may have resulted in missing differences in IL-6 and TNF-α
production, which are typically induced earlier, increasing immediately after incubation
and peaking 4 h after [39]. Furthermore, it should also be considered that while other
studies used isolated monocytes, in this study, LPS stimulation of whole-blood cultures
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was used. It has been considered that this model probably comes closest to the natural
environment, avoiding artifacts from preparation and allowing natural interactions [3].
Regarding the analysis of age influence, it should be noted that age groups considered in
the analysis of cytokine production were arbitrarily chosen, and this distribution resulted in
different numbers of participants in each age group, with a higher number of participants
aged 20–29 years. Hormone levels were not measured in women to find out the effects
of hormone concentrations on cytokine production. Therefore, an objective association
between hormone levels and cytokine production could not be established.
5. Conclusions
Sex, age, and smoking were found to be independent determinants of stimulated
cytokine production. While the female sex was associated with higher IL-10 and lower
TNF-α production, aging was associated with lower levels of stimulated IL-6, TNF-α, and
IL-10 production. Regarding changes with age, it is noteworthy that significantly decreased
values for IL-6 and TNF-α production were observed in individuals aged around 50 years
old. Therefore, when LPS-stimulated cytokine production is analyzed in patients with
diseases, the effect of age, and also differences between sexes, should be considered as
confounding factors.
Author Contributions: Conceptualization, P.T.; methodology, P.T., S.M., A.R.-S. and L.R.; formal
analysis, P.T. and H.J.M.; investigation, L.R., S.M., A.R.-S. and P.T.; resources, P.T. and S.M., data
curation, L.R. and P.T.; writing—original draft preparation, L.R.; writing—review and editing, P.T.,
A.R.-S., H.J.M. and S.M.; visualization, L.R.; supervision, P.T. and S.M.; project Administration, P.T.
and S.M.; funding acquisition, P.T. and S.M. All authors have read and agreed to the published
version of the manuscript.
Funding: This research was funded by the Ministerio de Economía, Industria y Competitividad
(MINECO), the Agencia Estatal de Investigación (AEI) and the European Regional Development
Funds (ERDF), project DEP2013–45966-p (MINECO/AEI/ERDF, EU).
Institutional Review Board Statement: The study was conducted according to the guidelines of
the Declaration of Helsinki and approved by the Balearic Islands Clinical Investigation Ethics
Committee (IB 2399/14 PI).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: The data presented in this study are available on request from the
corresponding author.
Acknowledgments: The authors would like to thank all the participants in the study.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or
in the decision to publish the results.
References
1. Abbasi, A.; Fehrenbach, E.; Hauth, M.; Walter, M.; Hudemann, J.; Wank, V.; Niess, A.M.; Northoff, H. Changes in spontaneous
and lps-induced ex vivo cytokine production and mrna expression in male and female athletes following prolonged exhaustive
exercise. Exerc. Immunol. Rev. 2013, 19, 8–28. [PubMed]
2. Beenakker, K.G.M.; Westendorp, R.G.J.; De Craen, A.J.M.; Chen, S.; Raz, Y.; Ballieux, B.E.P.B.; Nelissen, R.G.H.H.; Later, A.F.L.;
Huizinga, T.W.; Slagboom, P.E.; et al. Men Have a Stronger Monocyte-Derived Cytokine Production Response upon Stimulation
with the Gram-Negative Stimulus Lipopolysaccharide than Women: A Pooled Analysis Including 15 Study Populations.
J. Innate Immun. 2020, 12, 142–153. [CrossRef]
3. Damsgaard, C.T.; Lauritzen, L.; Calder, P.C.; Kjær, T.M.R.; Frøkiær, H. Whole-blood culture is a valid low-cost method to measure
monocytic cytokines—A comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes.
J. Immunol. Methods 2009, 340, 95–101. [CrossRef] [PubMed]
4. De Craen, A.J.M.; Posthuma, D.; Remarque, E.J.; van den Biggelaar, A.H.J.; Westendorp, R.G.J.; Boomsma, D.I. Heritability
estimates of innate immunity: An extended twin study. Genes Immun. 2005, 6, 167–170. [CrossRef]
Cells 2022, 11, 103 11 of 12
5. Gon, Y.; Hashimoto, S.; Hayashi, S.; Koura, T.; Matsumoto, K.; Horie, T. Lower serum concentrations of cytokines in elderly patients
with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin. Exp. Immunol.
1996, 106, 120–126.
6. Wijsman, C.A.; Maier, A.B.; De Craen, A.J.M.; Van Den Biggelaar, A.H.J.; Westendorp, R.G.J. An unopposed proinflammatory
response is beneficial for survival in the oldest old. Results of the Leiden 85-plus study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2011,
66 A, 393–399. [CrossRef]
7. Van Exel, E.; Gussekloo, J.; De Craen, A.J.M.; Frölich, M.; Van Der Wiel, A.B.; Westendorp, R.G.J. Low production capacity of
interleukin-10 associates with the metabolic syndrome and type 2 diabetes: The Leiden 85-plus study. Diabetes 2002, 51, 1088–1092.
[CrossRef]
8. Rozing, M.P.; Westendorp, R.G.J.; Maier, A.B.; Wijsman, C.A.; Frölich, M.; De Craen, A.J.M.; Van Heemst, D. Serum triiodothyro-
nine levels and inflammatory cytokine production capacity. Age 2012, 34, 195–201. [CrossRef]
9. Beenakker, K.G.M.; Westendorp, R.G.J.; De Craen, A.J.M.; Slagboom, P.E.; Van Heemst, D.; Maier, A.B. Pro-inflammatory capacity
of classically activated monocytes relates positively to muscle mass and strength. Aging Cell 2013, 12, 682–689. [CrossRef]
[PubMed]
10. Lisi, L.; Camardese, G.; Treglia, M.; Tringali, G.; Carrozza, C.; Janiri, L.; Dello Russo, C.; Navarra, P. Monocytes from Depressed
Patients Display an Altered Pattern of Response to Endotoxin Challenge. PLoS ONE 2013, 8, e52585.
11. Bruunsgaard, H.; Pedersen, A.N.; Schroll, M.; Skinhoj, P.; Pedersen, B.K. Impaired production of proinflammatory cytokines in
response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp. Immunol. 1999, 118, 235–241. [CrossRef] [PubMed]
12. Auger, G.; Corvec, S.; Roquilly, A.; Segain, J.P.; Lepelletier, D.; Reynaud, A.; Asehnoune, K. Escherichia coli-induced productions
of pro-inflammatory cytokines are regulated by MAP kinases and G-protein but not by Akt: Relationship with phylogenetic
groups and resistance patterns. Cytokine 2011, 56, 290–297. [CrossRef] [PubMed]
13. Heesen, M.; Bloemeke, B.; Heussen, N.; Kunz, D. Can the interleukin-6 response to endotoxin be predicted? Studies of the
influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and
inflammatory cytokines. Crit. Care Med. 2002, 30, 664–669. [CrossRef]
14. Lynch, E.A.; Dinarello, C.A.; Cannon, J.G. Gender differences in IL-1α, IL-1β, and IL-1 receptor antagonist secretion from
mononuclear cells and urinary excretion. J. Immunol. 1994, 153, 300–306. [PubMed]
15. Ter Horst, R.; Jaeger, M.; Smeekens, S.P.; Oosting, M.; Swertz, M.A.; Li, Y.; Kumar, V.; Diavatopoulos, D.A.; Jansen, A.F.M.;
Lemmers, H.; et al. Host and Environmental Factors Influencing Individual Human Cytokine Responses. Cell 2016, 167, 1111–1124.
[CrossRef]
16. Segre, E.; Fullerton, J.N. Stimulated whole blood cytokine release as a biomarker of immunosuppression in the critically ill: The
need for a standardized methodology. Shock 2016, 45, 490–494. [CrossRef]
17. Drewry, A.M.; Ablordeppey, E.A.; Murray, E.T.; Beiter, E.R.; Walton, A.H.; Hall, M.W.; Hotchkiss, R.S. Comparison of monocyte
human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe
sepsis: A prospective observational study. Crit. Care 2016, 20, 334. [CrossRef]
18. Hall, M.W.; Knatz, N.L.; Vetterly, C.; Tomarello, S.; Wewers, M.D.; Volk, H.D.; Carcillo, J.A. Immunoparalysis and nosocomial
infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011, 37, 525–532. [CrossRef]
19. Döcke, W.D.; Randow, F.; Syrbe, U.; Krausch, D.; Asadullah, K.; Reinke, P.; Volk, H.D.; Kox, W. Monocyte deactivation in septic
patients: Restoration by IFN-γ treatment. Nat. Med. 1997, 3, 678–681. [CrossRef]
20. Simon, A.K.; Hollander, G.A.; McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. R. Soc. B
Biol. Sci. 2015, 282, 20143085. [CrossRef]
21. Martínez de Toda, I.; Maté, I.; Vida, C.; Cruces, J.; De la Fuente, M. Immune function parameters as markers of biological age and
predictors of longevity. Aging 2016, 8, 3110–3119. [CrossRef]
22. Westendorp, R.G.J.; Van Dunne, F.M.; Kirkwood, T.B.L.; Helmerhorst, F.M.; Huizinga, T.W.J. Optimizing human fertility and
survival. Nat. Med. 2001, 7, 873. [CrossRef]
23. Gleeson, M.; Bishop, N.; Oliveira, M.; McCauley, T.; Tauler, P.; Muhamad, A.S. Respiratory infection risk in athletes: Association
with antigen-stimulated IL-10 production and salivary IgA secretion. Scand. J. Med. Sci. Sports 2012, 22, 410–417. [CrossRef]
[PubMed]
24. Smit, L.A.M.; Heederik, D.; Doekes, G.; Krop, E.J.M.; Rijkers, G.T.; Wouters, I.M. Ex vivo cytokine release reflects sensitivity to
occupational endotoxin exposure. Eur. Respir. J. 2009, 34, 795–802. [CrossRef]
25. Westendorp, R.G.J.; Langermans, J.A.M.; Huizinga, T.W.J.; Elouali, A.H.; Verweij, C.L.; Boomsma, D.I.; Vandenbrouke, J.P. Genetic
influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349, 170–173. [CrossRef]
26. Van der Linden, M.W.; Westendorp, R.G.J.; Sturk, A.; Bergman, W.; Huizinga, T.W.J. High interleukin-10 production in first-degree
relatives of patients with generalized but not cutaneous lupus erythematosus. J. Investig. Med. 2000, 48, 327–334. [PubMed]
27. De Jong, B.A.; Huizinga, T.W.J.; Bollen, E.L.E.M.; Uitdehaag, B.M.J.; Bosma, G.P.T.; Van Buchem, M.A.; Remarque, E.J.;
Burgmans, A.C.S.; Kalkers, N.F.; Polman, C.H.; et al. Production of IL-1β and IL-1Ra as risk factors for susceptibility and
progression of relapse-onset multiple sclerosis. J. Neuroimmunol. 2002, 126, 172–179. [CrossRef]
28. Von Aulock, S.; Deininger, S.; Draing, C.; Gueinzius, K.; Dehus, O.; Hermann, C. Gender difference in cytokine secretion on
immune stimulation with LPS and LTA. J. Interf. Cytokine Res. 2006, 26, 887–892. [CrossRef]
Cells 2022, 11, 103 12 of 12
29. Dombrovskiy, V.Y.; Martin, A.A.; Sunderram, J.; Paz, H.L. Rapid increase in hospitalization and mortality rates for severe sepsis
in the United States: A trend analysis from 1993 to 2003. Crit. Care Med. 2007, 35, 1244–1250. [CrossRef]
30. Sopori, M. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2002, 2, 372–377. [CrossRef]
31. Chen, H.; Cowan, M.J.; Hasday, J.D.; Vogel, S.N.; Medvedev, A.E. Tobacco Smoking Inhibits Expression of Proinflammatory
Cytokines and Activation of IL-1R-Associated Kinase, p38, and NF-κB in Alveolar Macrophages Stimulated with TLR2 and TLR4
Agonists. J. Immunol. 2007, 179, 6097–6106. [CrossRef] [PubMed]
32. Van Zyl-Smit, R.N.; Binder, A.; Meldau, R.; Semple, P.L.; Evans, A.; Smith, P.; Bateman, E.D.; Dheda, K. Cigarette smoke impairs
cytokine responses and BCG containment in alveolar macrophages. Thorax 2014, 69, 363–370. [CrossRef] [PubMed]
33. Matsunaga, K.; Klein, T.W.; Friedman, H.; Yamamoto, Y. Involvement of Nicotinic Acetylcholine Receptors in Suppression of
Antimicrobial Activity and Cytokine Responses of Alveolar Macrophages to Legionella pneumophila Infection by Nicotine.
J. Immunol. 2001, 167, 6518–6524. [CrossRef]
34. Li, Z.G.; Danis, V.A.; Brooks, P.M. Effect of gonadal steroids on the production of IL-1 and IL-6 blood mononuclear cells in vitro.
Clin. Exp. Rheumatol. 1993, 11, 157–162. [PubMed]
35. Pacifici, R.; Brown, C.; Puscheck, E.; Friedrich, E.; Slatopolsky, E.; Maggio, D.; Mccracken, R.; Avioli, L.V. Effect of surgical
menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA 1991,
88, 5134–5138. [CrossRef]
36. Allen, A.M.; McRae-Clark, A.L.; Carlson, S.; Saladin, M.E.; Gray, K.M.; Wetherington, C.L.; McKee, S.A.; Allen, S.S. Determining
menstrual phase in human biobehavioral research: A review with recommendations. Exp. Clin. Psychopharmacol. 2016, 24, 1–11.
[CrossRef]
37. Straub, R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28, 521–574. [CrossRef]
38. Angstwurm, M.W.A.; Gärtner, R.; Ziegler-Heitbrock, H.W.L. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine
1997, 9, 370–374. [CrossRef]
39. Janský, L.; Reymanová, P.; Kopecký, J. Dynamics of Cytokine Production in Human Peripheral Blood Mononuclear Cells
Stimulated by LPS or Infected by Borrelia. Physiol. Res. 2003, 52, 593–598.
